255.16
price down icon0.41%   -1.05
after-market Dopo l'orario di chiusura: 255.16
loading
Precedente Chiudi:
$256.21
Aprire:
$255.92
Volume 24 ore:
1.50M
Relative Volume:
1.52
Capitalizzazione di mercato:
$37.05B
Reddito:
$5.02B
Utile/perdita netta:
$1.31B
Rapporto P/E:
28.64
EPS:
8.91
Flusso di cassa netto:
$1.56B
1 W Prestazione:
+0.58%
1M Prestazione:
+3.63%
6M Prestazione:
+9.43%
1 anno Prestazione:
+33.19%
Intervallo 1D:
Value
$250.88
$256.37
Intervallo di 1 settimana:
Value
$250.84
$260.23
Portata 52W:
Value
$186.22
$263.05

Resmed Inc Stock (RMD) Company Profile

Name
Nome
Resmed Inc
Name
Telefono
(858) 746-2400
Name
Indirizzo
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Name
Dipendente
9,980
Name
Cinguettio
@resmed
Name
Prossima data di guadagno
2024-10-24
Name
Ultimi documenti SEC
Name
RMD's Discussions on Twitter

Confronta RMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Instruments & Supplies icon
RMD
Resmed Inc
255.16 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
533.71 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
170.86 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
87.81 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
218.87 16.36B 2.90B 467.20M 306.90M 6.37

Resmed Inc Stock (RMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-19 Iniziato Morgan Stanley Overweight
2025-01-16 Iniziato Goldman Buy
2025-01-10 Iniziato Piper Sandler Neutral
2024-12-13 Iniziato Stifel Hold
2024-09-24 Iniziato Robert W. Baird Outperform
2024-09-18 Downgrade Wolfe Research Peer Perform → Underperform
2024-09-04 Downgrade Needham Buy → Hold
2024-06-25 Downgrade Oppenheimer Outperform → Perform
2024-06-24 Downgrade Citigroup Buy → Neutral
2024-02-06 Ripresa KeyBanc Capital Markets Overweight
2023-10-27 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2023-10-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2023-10-09 Aggiornamento JP Morgan Neutral → Overweight
2023-09-29 Downgrade Wolfe Research Outperform → Peer Perform
2023-09-06 Aggiornamento Needham Hold → Buy
2023-09-05 Downgrade UBS Buy → Neutral
2023-08-01 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-05-23 Iniziato UBS Buy
2023-04-14 Iniziato Mizuho Buy
2023-01-17 Aggiornamento JP Morgan Neutral → Overweight
2022-10-28 Downgrade Citigroup Buy → Neutral
2022-10-20 Aggiornamento BofA Securities Neutral → Buy
2022-10-12 Iniziato Jefferies Hold
2022-09-08 Aggiornamento Citigroup Neutral → Buy
2022-08-15 Downgrade CLSA Buy → Outperform
2022-08-12 Downgrade Citigroup Buy → Neutral
2022-08-12 Downgrade JP Morgan Overweight → Neutral
2022-08-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2022-06-06 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2022-04-06 Iniziato Wolfe Research Outperform
2022-01-31 Aggiornamento Citigroup Neutral → Buy
2022-01-31 Aggiornamento Goldman Neutral → Buy
2022-01-28 Aggiornamento RBC Capital Mkts Underperform → Sector Perform
2022-01-24 Aggiornamento BofA Securities Underperform → Neutral
2022-01-24 Aggiornamento JP Morgan Neutral → Overweight
2022-01-13 Aggiornamento CLSA Outperform → Buy
2022-01-13 Aggiornamento Robert W. Baird Neutral → Outperform
2021-12-21 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2021-12-06 Aggiornamento Macquarie Neutral → Outperform
2021-10-22 Aggiornamento CLSA Underperform → Outperform
2021-08-02 Downgrade CLSA Outperform → Sell
2021-08-02 Downgrade Needham Buy → Hold
2021-07-28 Aggiornamento Jefferies Underperform → Hold
2021-07-26 Downgrade JP Morgan Overweight → Neutral
2021-07-14 Iniziato RBC Capital Mkts Underperform
2021-06-28 Downgrade Citigroup Buy → Neutral
2021-06-22 Aggiornamento Macquarie Neutral → Outperform
2021-06-22 Iniziato Robert W. Baird Neutral
2021-06-21 Reiterato Needham Buy
2021-06-16 Downgrade BofA Securities Neutral → Underperform
2021-06-09 Aggiornamento CLSA Sell → Outperform
2021-05-21 Aggiornamento JP Morgan Neutral → Overweight
2021-05-11 Aggiornamento Citigroup Neutral → Buy
2021-04-30 Downgrade Citigroup Buy → Neutral
2021-03-16 Aggiornamento Needham Hold → Buy
2020-11-02 Aggiornamento UBS Neutral → Buy
2020-10-30 Aggiornamento JP Morgan Underweight → Neutral
2020-10-27 Aggiornamento BofA Securities Underperform → Neutral
2020-08-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-06-17 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-05-01 Downgrade JP Morgan Neutral → Underweight
2020-05-01 Aggiornamento Oppenheimer Perform → Outperform
2020-02-18 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-02-03 Iniziato CLSA Underperform
2020-01-31 Downgrade UBS Buy → Neutral
2020-01-10 Iniziato Oppenheimer Perform
2019-11-22 Iniziato KeyBanc Capital Markets Sector Weight
2019-07-29 Aggiornamento UBS Neutral → Buy
2019-07-16 Downgrade UBS Buy → Neutral
2019-05-06 Aggiornamento UBS Neutral → Buy
2019-04-18 Aggiornamento JP Morgan Underweight → Neutral
2019-01-25 Downgrade Goldman Buy → Neutral
2019-01-25 Downgrade JP Morgan Neutral → Underweight
2018-10-26 Aggiornamento Credit Suisse Neutral → Outperform
2018-07-02 Iniziato Goldman Buy
Mostra tutto

Resmed Inc Borsa (RMD) Ultime notizie

pulisher
Jun 19, 2025

Is the ResMed share price still cheap? What the numbers say - The Motley Fool Australia

Jun 19, 2025
pulisher
Jun 18, 2025

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

Jun 18, 2025
pulisher
Jun 17, 2025

Bi Level Automatic Ventilator Market Is Booming Worldwide 2025-2032 | ResMed Inc., Philips Healthcare, Medtronic Plc - openPR.com

Jun 17, 2025
pulisher
Jun 16, 2025

ResMed Stock: Is RMD Outperforming the Healthcare Sector? - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

ResMed Inc. (RMD) Investor Outlook: Analyzing Growth Potential Amidst a 6% Upside - DirectorsTalk Interviews

Jun 16, 2025
pulisher
Jun 10, 2025

Resmed CEO Michael Farrell sells shares worth $2.01 million By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

ResMed: A Mixed Bag for Investors Amid Rising Competition - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

Resmed CEO Michael Farrell sells shares worth $2.01 million - Investing.com

Jun 10, 2025
pulisher
Jun 09, 2025

ResMed CEO Sells Shares Worth $2 Million - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

ResMed Inc Reports Change in Beneficial Ownership - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

ResMed: A Sleeping Giant Hiding In Plain Sight (NYSE:RMD) - Seeking Alpha

Jun 09, 2025
pulisher
Jun 08, 2025

Up more than 75% since October 2023 — are ResMed shares a buy, hold or sell? - MSN

Jun 08, 2025
pulisher
Jun 06, 2025

Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD) - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

ResMed director Peter Farrell sells $494,640 in stock By Investing.com - Investing.com Nigeria

Jun 06, 2025
pulisher
Jun 06, 2025

ResMed director Peter Farrell sells $494,640 in stock - Investing.com Australia

Jun 06, 2025
pulisher
Jun 05, 2025

ResMed Inc Director Proposes Sale of Common Shares - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Successful Exits - University College Dublin

Jun 05, 2025
pulisher
Jun 04, 2025

ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Insider Sell: Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) - GuruFocus

Jun 04, 2025
pulisher
Jun 03, 2025

ResMed CFO Sells Shares - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Resmed Inc Reports Decrease in CDI Issuance for May 2025 - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

ResMed CFO Executes Stock Sale Under Rule 10b5-1 Plan - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

ResMed Inc. Officer Files Notice for Proposed Sale of Securities - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

ResMed’s global general counsel Michael Rider sells $9,994 in shares By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

ResMed’s global general counsel Michael Rider sells $9,994 in shares - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Dental Sleep Medicine Market Projected to Witness Massive GrowthResMed Inc., SomnoMed Limited - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

Citi raises ResMed stock price target to AUD45 citing strong EPS growth - Investing.com Nigeria

Jun 02, 2025
pulisher
Jun 02, 2025

Here's why I invested MORE money in ResMed shares last week - MSN

Jun 02, 2025
pulisher
May 30, 2025

There's Reason For Concern Over ResMed Inc.'s (NYSE:RMD) Price - simplywall.st

May 30, 2025
pulisher
May 30, 2025

Sleep Apnea Oral Appliances MarketGlobal Forecast to 2030 with SomnoMed, Resmed, ProSomnus, DynaFlex, Vivos Therapeutics, and OpenAirway Leading - Yahoo Finance

May 30, 2025
pulisher
May 29, 2025

ResMed Inc. Files Conflict Minerals Disclosure Report for 2024 - TipRanks

May 29, 2025
pulisher
May 28, 2025

Actigraphy Devices Market Report 2025-2034 | Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape - GlobeNewswire Inc.

May 28, 2025
pulisher
May 27, 2025

ResMed CFO Executes Stock Transaction Under Rule 10b5-1 Plan - TipRanks

May 27, 2025
pulisher
May 27, 2025

ResMed CFO Brett Sandercock sells $891,285 in stock By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

Hedge Fund and Insider Trading News: Bill Ackman, Paul Tudor Jones, Chase Coleman, John Paulson, Polus Capital Management, VFC Corp (VFC), ResMed Inc (RMD), and More - Insider Monkey

May 27, 2025
pulisher
May 27, 2025

ResMed CFO Brett Sandercock sells $891,285 in stock - Investing.com Australia

May 27, 2025
pulisher
May 26, 2025

Equities Analysts Issue Forecasts for ResMed Q1 Earnings - Defense World

May 26, 2025
pulisher
May 24, 2025

ResMed’s SWOT analysis: sleep tech giant faces growth challenges, new markets - Investing.com

May 24, 2025
pulisher
May 23, 2025

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue? - Yahoo Finance

May 23, 2025
pulisher
May 23, 2025

Are Wall Street Analysts Bullish on ResMed Stock? - Inkl

May 23, 2025
pulisher
May 23, 2025

Are Wall Street Analysts Bullish On ResMed Stock? - Barchart.com

May 23, 2025
pulisher
May 23, 2025

Is it Worth Retaining ResMed Stock in Your Portfolio Now? - Nasdaq

May 23, 2025
pulisher
May 23, 2025

Insider Sell: Witte De Sells 2,000 Shares of ResMed Inc (RMD) - GuruFocus

May 23, 2025
pulisher
May 22, 2025

Why Kogan, Monash IVF, OFX, and ResMed shares are falling today - MSN

May 22, 2025

Resmed Inc Azioni (RMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Resmed Inc Azioni (RMD) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Farrell Michael J.
Chief Executive Officer
Jun 09 '25
Sale
251.21
8,009
2,011,910
455,503
medical_instruments_supplies ALC
$87.81
price up icon 0.80%
medical_instruments_supplies BDX
$170.86
price up icon 0.52%
medical_instruments_supplies WST
$218.87
price down icon 0.06%
medical_instruments_supplies BAX
$30.39
price down icon 0.36%
$65.01
price down icon 0.15%
Capitalizzazione:     |  Volume (24 ore):